Mupirocina Isdin (Mupirocin)

Mupirocin blocks the bacterial enzyme isoleucyl‑tRNA synthetase, which is required for protein synthesis. By preventing the incorporation of isoleucine into bacterial proteins, the drug stops bacterial growth and can kill susceptible organisms, reducing the bacterial load in the affected skin area.

The dosage of Mupirocina Isdin is determined by the prescribing clinician based on the infection type, severity, patient age and body surface area. Typically, a thin layer is applied to the affected area one to three times daily, but the exact regimen should follow the prescriber’s instructions.

Safety data for topical mupirocin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To order Mupirocina Isdin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Mupirocina Isdin offers a narrow‑spectrum activity primarily against Staphylococcus aureus and Streptococcus pyogenes, with a low risk of resistance compared with some other topical agents. Unlike bacitracin or neomycin, mupirocin has a well‑documented safety profile and is often preferred for impetigo and folliculitis.

Mupirocina Isdin should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and potency throughout its shelf life.

The product is applied topically to clean, dry skin. A thin layer should be spread over the affected area and gently rubbed in. It is usually applied once to three times daily, depending on the prescriber’s directions, and the treated area should be covered with a sterile dressing only if advised.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, contact dermatitis with extensive skin involvement, and systemic effects like neutropenia from significant absorption. Patients should stop use and seek immediate medical attention if they experience swelling, difficulty breathing, or widespread rash.

Mupirocina Isdin should not be used by individuals with a known hypersensitivity to mupirocin or any component of the formulation. It is also contraindicated on large, broken skin surfaces, mucous membranes, or in patients with a history of severe allergic reactions to topical antibiotics.